Jeff Yass’s Albany Molecular Research Inc AMRI Stock Holding History

Jeff Yass’s Portfolio AMRI Stock Details AMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-48,841	Closed	-$943K	–	10702
2015 Q1	$860K	Buy	+48,841	New	+$832K	﹤0.01%	6064
2014 Q1	–	Sell	-11,185	Closed	-$154K	–	9735
2013 Q4	$113K	Buy	+11,185	New	+$135K	﹤0.01%	8586

Other funds holding AMRI

Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Jeff Yass's AMRI Position: Q2 2015 in Review

Jeff Yass sold out of Albany Molecular Research Inc (AMRI) in Q2 2015, closing a stake of 48,841 shares — an estimated $943K sold.

Jeff Yass first reported a position in AMRI in Q4 2013 and held it in 2 quarters. The position peaked at $860K in Q1 2015. 131 funds tracked by Wall St. Rank hold AMRI as of Q2 2015.

Jeff Yass reported no remaining Albany Molecular Research Inc position as of Q2 2015 after selling out during the quarter.
Jeff Yass sold 48,841 Albany Molecular Research Inc shares in Q2 2015, an estimated $943K.
Jeff Yass first reported a position in Albany Molecular Research Inc in Q4 2013 and held it in 2 quarters.
Jeff Yass's Albany Molecular Research Inc position peaked at $860K in Q1 2015.
131 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q2 2015.

Based on Susquehanna International Group's 13F filing for Q2 2015, filed 14 Aug 2015.